Hirofumi Ando

478 total citations
35 papers, 353 citations indexed

About

Hirofumi Ando is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Hirofumi Ando has authored 35 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 6 papers in Surgery. Recurrent topics in Hirofumi Ando's work include Liver Disease Diagnosis and Treatment (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Hirofumi Ando is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Hirofumi Ando collaborates with scholars based in Japan and United States. Hirofumi Ando's co-authors include Tanri Shiozawa, Tsutomu Miyamoto, Ryoichi Asaka, Yasushi Yamada, Hiroyasu Kashima, Yoshimasa Sakamoto, Tatsuya Nakatani, Kunio Kobayashi, Ichiro Kaneko and Yasunari Fujinaga and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Surgical Pathology.

In The Last Decade

Hirofumi Ando

30 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirofumi Ando Japan 9 123 98 74 60 58 35 353
Beatriz Santamaría Spain 14 202 1.6× 43 0.4× 61 0.8× 5 0.1× 59 1.0× 24 574
M. Byrne Ireland 5 49 0.4× 23 0.2× 39 0.5× 20 0.3× 21 0.4× 7 398
Shiro Imai Japan 13 96 0.8× 10 0.1× 22 0.3× 82 1.4× 17 0.3× 40 573
Xiaomeng Feng China 12 245 2.0× 16 0.2× 57 0.8× 10 0.2× 158 2.7× 21 552
Tına Mistry United Kingdom 6 80 0.7× 25 0.3× 189 2.6× 8 0.1× 116 2.0× 9 392
Kaitao Yuan China 11 104 0.8× 75 0.8× 15 0.2× 4 0.1× 84 1.4× 20 424
ASTRID M. PEDERSEN Denmark 7 89 0.7× 28 0.3× 6 0.1× 15 0.3× 25 0.4× 7 388
Soon-Tae Park South Korea 14 155 1.3× 15 0.2× 33 0.4× 5 0.1× 64 1.1× 33 569
Jiacheng Wu China 9 108 0.9× 6 0.1× 81 1.1× 9 0.1× 73 1.3× 20 319

Countries citing papers authored by Hirofumi Ando

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Ando more than expected).

Fields of papers citing papers by Hirofumi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Ando. The network helps show where Hirofumi Ando may publish in the future.

Co-authorship network of co-authors of Hirofumi Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Ando. A scholar is included among the top collaborators of Hirofumi Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Ando. Hirofumi Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyamoto, Tsutomu, Shiho Asaka, Yoshinori Sato, et al.. (2025). Extensive Pathologic Invasion and Prognostic Implication of Gastric-Type Cervical Adenocarcinoma. The American Journal of Surgical Pathology. 49(5). 471–480.
2.
3.
Ando, Hirofumi, Tsutomu Miyamoto, Ryoichi Asaka, et al.. (2024). Usefulness of decision tree analysis of MRI features for diagnosis of placenta accreta spectrum in cases with placenta previa. Japanese Journal of Radiology. 43(3). 492–501. 1 indexed citations
4.
Miyamoto, Tsutomu, et al.. (2023). Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells. Discover Oncology. 14(1). 9–9. 3 indexed citations
5.
Miyamoto, Tsutomu, et al.. (2020). Limited frequency of malignant change in lobular endocervical glandular hyperplasia. International Journal of Gynecological Cancer. 30(10). 1480–1487. 6 indexed citations
6.
Motoki, Hirohiko, Tatsuya Saigusa, Soichiro Ebisawa, et al.. (2019). Biopsy detection and clinical management of acute lymphocytic myocarditis in pregnancy. Journal of Cardiology Cases. 20(5). 164–167. 1 indexed citations
7.
Ohira, Satoshi, Ryoichi Asaka, Hirofumi Ando, et al.. (2019). Sawtooth fetal heart rate pattern associated with a favorable neurological outcome in an infant: a case report. Journal of Medical Case Reports. 13(1). 226–226. 2 indexed citations
8.
Komatsu, Toshinori, Hirohiko Motoki, Kazuhiro Kimura, et al.. (2018). A case of thrombolytic therapy with recombinant tissue plasminogen activator for mechanical valve thrombosis at 9 weeks of pregnancy in a Japanese woman. Journal of Cardiology Cases. 19(1). 15–18.
9.
Miyamoto, Tsutomu, Hirofumi Ando, Ryoichi Asaka, Yasushi Yamada, & Tanri Shiozawa. (2017). Mutation analysis by whole exome sequencing of endometrial hyperplasia and carcinoma in one patient: Abnormalities of polymerase epsilon and the phosphatidylinositol‐3 kinase pathway. Journal of obstetrics and gynaecology research. 44(1). 179–183. 8 indexed citations
10.
Miyamoto, Tsutomu, Ryoichi Asaka, Yasushi Yamada, et al.. (2017). SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells. Translational Oncology. 10(4). 621–631. 43 indexed citations
11.
12.
Kikuchi, Norihiko, Satoshi Ohira, Ryoichi Asaka, et al.. (2016). A Case of Vaginal Varices that Caused Massive Bleeding after Vaginal Delivery. 64(1). 35–39. 2 indexed citations
13.
Miyamoto, Tsutomu, Hiroyasu Kashima, Yasushi Yamada, et al.. (2016). Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells. PLoS ONE. 11(5). e0155220–e0155220. 33 indexed citations
14.
Hayashi, Takuma, Tomoyuki Ichimura, Hirofumi Ando, et al.. (2016). Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma. Anticancer Research. 36(10). 4997–5008. 6 indexed citations
15.
Miyamoto, Tsutomu, Ryoichi Asaka, Yasushi Yamada, et al.. (2016). Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma. Applied immunohistochemistry & molecular morphology. 25(6). 415–421. 40 indexed citations
16.
Asaka, Ryoichi, et al.. (2015). Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target. Laboratory Investigation. 95(12). 1363–1373. 73 indexed citations
17.
Sakamoto, Yoshimasa, et al.. (1998). Effects of Intra-abdominal Hypertension on Hepatic Energy Metabolism in a Rabbit Model. PubMed. 44(3). 446–453. 18 indexed citations
18.
Nakatani, Tatsuya, Yoshimasa Sakamoto, Hirofumi Ando, & Kunio Kobayashi. (1996). Enhanced ketogenesis in the kidney during hepatic inflow occlusion with the administration of Ringer's acetate solution. Surgery. 119(6). 684–689. 9 indexed citations
19.
Nakatani, Tatsuya, Yoshimasa Sakamoto, Hirofumi Ando, & Kunio Kobayashi. (1995). Bile and Bilirubin Excretion in Relation to Hepatic Energy Status Hemorrhagic Shock and Hypoxemia in Rabbits. PubMed. 39(4). 665–670. 8 indexed citations
20.
Nakatani, Tatsuya, Yoshimasa Sakamoto, Hirofumi Ando, & Kunio Kobayashi. (1995). EFFECTS OF RINGERʼS ACETATE SOLUTION DURING TRANSIENT HEPATIC INFLOW OCCLUSION IN RABBITS. Transplantation. 59(7). 952–957. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Santamaría Breakdown of academic impact, for papers by M. Byrne Breakdown of academic impact, for papers by Shiro Imai Breakdown of academic impact, for papers by Xiaomeng Feng Breakdown of academic impact, for papers by Tına Mistry Breakdown of academic impact, for papers by Kaitao Yuan Breakdown of academic impact, for papers by ASTRID M. PEDERSEN Breakdown of academic impact, for papers by Soon-Tae Park Breakdown of academic impact, for papers by Jiacheng Wu
Rankless by CCL
2026